BRAF gene is frequently mutated in a wide range of tumors, particularly in skin cutaneous melanoma and thyroid carcinoma (Fig. 4A), and activating mutations in BRAF lead to continuous stimulation of the ERK signaling pathway45. This evidence concerns the gene BRAF and thyroid gland carcinoma.